Chugai Pharmaceutical Co (STU:CUP) Ending Cash Position : €2,628 Mil (As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is Chugai Pharmaceutical Co Ending Cash Position?

Chugai Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2025 was €2,628 Mil.

Chugai Pharmaceutical Co's quarterly Ending Cash Position declined from Sep. 2024 (€2,546 Mil) to Dec. 2024 (€846 Mil) but then increased from Dec. 2024 (€846 Mil) to Mar. 2025 (€2,628 Mil).

Chugai Pharmaceutical Co's annual Ending Cash Position increased from Dec. 2022 (€1,555 Mil) to Dec. 2023 (€2,921 Mil) and increased from Dec. 2023 (€2,921 Mil) to Dec. 2024 (€3,354 Mil).

Chugai Pharmaceutical Co Ending Cash Position Historical Data

The historical data trend for Chugai Pharmaceutical Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chugai Pharmaceutical Co Ending Cash Position Chart

Chugai Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

1,681.56

2,081.66

1,554.52

2,921.24

3,354.00

Chugai Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Ending Cash Position	Get a 7-Day Free Trial															2,842.33	2,317.27	2,546.04	845.91	2,627.59

Chugai Pharmaceutical Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Chugai Pharmaceutical Co's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2847.809	+	506.189
	=	3,354

Chugai Pharmaceutical Co's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	3352.308	+	-724.716
	=	2,628

Chugai Pharmaceutical Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Chugai Pharmaceutical Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Chugai Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chugai Pharmaceutical Co Ltd (STU:CUP) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

CHGCY:USA CHGCF:USA 4519N:Mexico 4519:Japan

Address

1-1 Nihonbashi-Muromachi 2-Chome, Nihonbashi Mitsui Tower (Reception15F), Chuo-ku, Tokyo, JPN, 103-8324

Website

http://www.chugai-pharm.co.jp

Chugai Pharmaceutical is a Japanese drug developer and subsidiary of Roche Holding, which owns roughly 60% of the company. Founded in 1925, Chugai deals primarily in the Japanese market, where it generates roughly half of its revenue. It has been the leader in Japan's oncology market for the past decade, largely due to drugs licensed from its parent's portfolio. The company also develops its own innovative medicines. It is an industry leader in antibody technology with several flagship therapies, including Hemlibra for hemophilia A patients and Actemra for treating rheumatoid arthritis and covid patients.

Chugai Pharmaceutical Co Headlines

No Headlines